Back to top
more

McKesson (MCK)

(Delayed Data from NYSE)

$589.99 USD

589.99
691,572

+4.25 (0.73%)

Updated Jul 24, 2024 04:00 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 42% (105 out of 250)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Cardinal Health's (CAH) Velocare to Enhance at-Home Care

by Zacks Equity Research

Cardinal Health's (CAH) latest launch is expected to significantly expand its at-Home Solutions supply chain and logistics services, thereby improving patient care.

3 Reasons to Retain Abbott (ABT) Stock in Your Portfolio

by Zacks Equity Research

Investors continue to be optimistic about Abbott (ABT) owing to the strength in its Diabetes business.

PerkinElmer's (PKI) New Marketing Approval to Aid Infant Health

by Zacks Equity Research

PerkinElmer's (PKI) EONIS SCID-SMA assay kit is expected to enable early SMA and SCID screening in newborns following the FDA's approval.

Phibro (PAHC) Q1 Earnings Miss Estimates, Sales Surpass

by Zacks Equity Research

Phibro's (PAHC) growing uptake of MFAs, dairy products and vaccines buoys optimism.

Here's Why You Should Retain Cooper Companies (COO) Stock Now

by Zacks Equity Research

Cooper Companies (COO) continues to benefit from strength in its business segments. Its acquisitions are likely to boost the top line further.

Patterson Companies' (PDCO) New Buyout to Expand Product Suite

by Zacks Equity Research

Patterson Companies' (PDCO) latest buyout is expected to significantly expand its Animal Health's product offerings.

DENTSPLY SIRONA (XRAY) Q3 Earnings & Revenues Miss Estimates

by Zacks Equity Research

Despite a year-over-year decline in both earnings and revenues, DENTSPLY SIRONA's (XRAY) third-quarter results benefit from the Technologies & Equipment business.

Myriad Genetics' (MYGN) UroSuite to Improve Tailored Treatment

by Zacks Equity Research

Myriad Genetics' (MYGN) latest launch is expected to aid clinicians with access to tools that can assist them with turnaround times and report interpretation.

Here's Why You Should Retain Patterson Companies (PDCO) Stock

by Zacks Equity Research

Investors remain optimistic about Patterson Companies (PDCO) on the back of its strong product line.

Abhinab Dasgupta headshot

Beat the Market Like Zacks: JPMorgan, Berkshire Hathaway, Amgen in Focus

by Abhinab Dasgupta

Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.

Here's Why You Should Retain Intuitive Surgical (ISRG) Stock

by Zacks Equity Research

Intuitive Surgical (ISRG) continues to gain traction from the improving adoption of the da Vinci Surgical System. Improving margins buoy optimism.

Patterson Companies (PDCO) Inks Deal to Expand Product Suite

by Zacks Equity Research

Patterson Companies' (PDCO) latest buyout is expected to significantly expand its value-add platform.

Nalak Das headshot

October CPI Data Raises Hope for a Soft Landing: 5 Top Picks

by Nalak Das

We have narrowed our search to five U.S. corporate behemoths with solid growth potential. These are: HUM, MPC, CAT, MCK and ORLY.

3 Reasons to Hold DexCom (DXCM) Stock in Your Portfolio

by Zacks Equity Research

Investors continue to be optimistic about DexCom (DXCM) owing to its strong product portfolio.

Zacks Industry Outlook Highlights Becton Dickinson, McKesson and AmerisourceBergen

by Zacks Equity Research

Becton Dickinson, McKesson and AmerisourceBergen have been highlighted in this Industry Outlook article.

Indrajit Bandyopadhyay headshot

3 Dental Supplies Stocks to Watch Amid Industry Headwinds

by Indrajit Bandyopadhyay

Here we discuss three stocks from the Dental Supplies industry that are likely to create wealth for investors - BDX, MCK and ABC.

Zacks.com featured highlights H&R Block, ParkerHannifin, Archer-Daniels-Midland, Insperity and McKesson

by Zacks Equity Research

H&R Block, ParkerHannifin, Archer-Daniels-Midland, Insperity and McKesson have been highlighted in this Screen of The Week article.

3 Reasons Growth Investors Will Love McKesson (MCK)

by Zacks Equity Research

McKesson (MCK) possesses solid growth attributes, which could help it handily outperform the market.

Sweta Killa headshot

Top 5 Dividend Stocks to Cheer You Up This Holiday Season

by Sweta Killa

We have selected five dividend growth stocks ¿¿¿ H&R Block (HRB), ParkerHannifin (PH), Archer-Daniels-Midland (ADM), Insperity (NSP) and McKesson (MCK) ¿¿¿ that could be compelling picks for your portfolio ahead of the holiday season.

Should IQ Chaikin U.S. Large Cap ETF (CLRG) Be on Your Investing Radar?

by Zacks Equity Research

Style Box ETF report for CLRG

Derek Lewis headshot

Invest Like Warren Buffett With These 3 Stocks

by Derek Lewis

Many investors mimic Warren Buffett, closely following all of his moves. And with his track record of success, it's easy to see why.

Is IQ Chaikin U.S. Large Cap ETF (CLRG) a Strong ETF Right Now?

by Zacks Equity Research

Smart Beta ETF report for CLRG

McKesson (MCK) Q2 Earnings Miss Estimates, Revenues Rise Y/Y

by Zacks Equity Research

McKesson's (MCK) fiscal second-quarter 2023 results benefit from segmental growth.

McKesson (MCK) Lags Q2 Earnings Estimates

by Zacks Equity Research

McKesson (MCK) delivered earnings and revenue surprises of -1.14% and 0.71%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Nalak Das headshot

Top 5 Stocks Set to Beat on Earnings After Markets Close

by Nalak Das

Five companies will report earnings results today after the closing bell. These are: CHK, MCK, ENLC, LTHM and ZI.